GOLDMAN SACHS GROUP INC - AVALO THERAPEUTICS INC ownership

AVALO THERAPEUTICS INC's ticker is and the CUSIP is 05338F207. A total of 29 filers reported holding AVALO THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of AVALO THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$56,457
-66.2%
32,261
-2.6%
0.00%
Q4 2022$166,868
+41.4%
33,108
-7.1%
0.00%
Q3 2022$118,00035,6440.00%
Other shareholders
AVALO THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
VR Adviser, LLC 1,250,000$444,0000.07%
Nantahala Capital Management 556,202$197,5630.02%
Virtu Financial LLC 32,593$120.00%
Kistler-Tiffany Companies, LLC 2$10.00%
VANGUARD GROUP INC 222,073$78,8800.00%
First Horizon Advisors, Inc. 276$980.00%
UBS Group AG 1,919$6800.00%
OSAIC HOLDINGS, INC. 334$1180.00%
Parallel Advisors, LLC 1$00.00%
BANK OF AMERICA CORP /DE/ 4,127$1,4650.00%
View complete list of AVALO THERAPEUTICS INC shareholders